Security key
M53071136
IceCure Medical Ltd. - Ordinary Shares, no par value (ICCM)
CUSIP: M53071136
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 3,249,330
- Total 13F value
- $976,776
- Share change
- +2,724,527
- SEC-reported price per share
- $0.30
- Number of holders
- 18
- Value change
- +$751,816
- Number of buys
- 9
- Number of sells
- 6
- Shares outstanding
- 78,267,679
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
18
Top holders
10
ICCM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
IceCure Medical Ltd. SEC filings
IceCure Medical Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M53071136
Recent filing periods:
Ownership snapshot
Top reported holders of ICCM - IceCure Medical Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Haixiang Li
Disclosed value leader
Haixiang Li
Comparable rows
15/15
Latest evidence
18 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 46%
13D/G row: Haixiang Li
Showing 1-6 of 15 holder rows.
Quick read
Haixiang Li leads the comparable SEC ownership view at 46%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Haixiang Li's linked filing trail.
Comparable ownership
Top 5
Haixiang Li
46%
Eyal Shamir
1%
Ron Mayron
0.38%
Tlalit Bussi Tel-Tzure
0.22%
Shad Good
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Haixiang Li |
13D/G
Mr. Li Haixiang
|
46%
|
$20,791,026
35,846,597 shares
|
+$5,800,000 | 17 Mar 2026 |
| Eyal Shamir |
3/4/5
Chief Executive Officer, Director
|
1%
|
$482,821
791,381 shares
|
— | 18 Mar 2026 |
| Ron Mayron |
3/4/5
Director
|
0.38%
|
$172,045
296,631 shares
|
— | 18 Mar 2026 |
| Tlalit Bussi Tel-Tzure |
3/4/5
VP, BD & Global Marketing
|
0.22%
|
$104,100
170,629 shares
|
— | 18 Mar 2026 |
| Shad Good |
3/4/5
VP, Sales for North America
|
0.2%
|
$95,453
156,455 shares
|
— | 18 Mar 2026 |
| Shay Levav |
3/4/5
Chief Operating Officer
|
0.18%
|
$88,229
144,615 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
3,249,330
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
19
Q1 2026 holders
18
Holder diff
-1
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend